Literature DB >> 16720635

Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura in the setting of adult-onset Still's disease.

S Hirata, H Okamoto, S Ohta, T Kobashigawa, M Uesato, Y Kawaguchi, M Tateishi, M Hara, N Kamatani, H-M Tsai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16720635      PMCID： PMC3152946          DOI： 10.1093/rheumatology/kel176

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  8 in total

1.  Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan.

Authors:  K Wakai; A Ohta; A Tamakoshi; Y Ohno; T Kawamura; R Aoki; M Kojima; Y Lin; S Hashimoto; Y Inaba; M Minowa; S Aizawa; Y Ichikawa; N Miyasaka
Journal:  J Epidemiol       Date:  1997-12       Impact factor: 3.211

2.  Inhibitors of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; A Li; G Rock
Journal:  Clin Lab       Date:  2001       Impact factor: 1.138

3.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

Review 4.  Thrombotic thrombocytopenic purpura in the setting of systemic sclerosis.

Authors:  Augustine M Manadan; Charlotte Harris; Joel A Block
Journal:  Semin Arthritis Rheum       Date:  2005-02       Impact factor: 5.532

Review 5.  Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus.

Authors:  F Musio; E M Bohen; C M Yuan; P G Welch
Journal:  Semin Arthritis Rheum       Date:  1998-08       Impact factor: 5.532

6.  Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; E C Lian
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

7.  von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

Authors:  M Furlan; R Robles; M Galbusera; G Remuzzi; P A Kyrle; B Brenner; M Krause; I Scharrer; V Aumann; U Mittler; M Solenthaler; B Lämmle
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

8.  Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis).

Authors:  Pier Mannuccio Mannucci; Massimo Vanoli; Ileana Forza; Maria Teresa Canciani; Raffaella Scorza
Journal:  Haematologica       Date:  2003-08       Impact factor: 9.941
  8 in total
  6 in total

1.  [Adult onset Still's disease].

Authors:  B Manger
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

Review 2.  Thrombotic microangiopathy in adult-onset Still's disease: case report and review of the literature.

Authors:  Lea Salamon; Tomislav Salamon; Jadranka Morovic-Vergles
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 3.  Mechanisms, biomarkers and targets for adult-onset Still's disease.

Authors:  Eugen Feist; Stéphane Mitrovic; Bruno Fautrel
Journal:  Nat Rev Rheumatol       Date:  2018-10       Impact factor: 20.543

4.  Coexistence of thrombotic thrombocytopenic purpura and adult-onset Still's disease.

Authors:  Raida Ben Salah; Yosra Bouattour; Chourouk Turki; Faten Frikha; Zouhir Bahloul
Journal:  Clin Case Rep       Date:  2022-02-23

Review 5.  Adult-onset Still's disease with concurrent thrombotic thrombocytopenic purpura: case report and literature review.

Authors:  Ryohei Kato; Tomoyuki Ikeuchi; Katsuyuki Tomita; Akira Yamasaki
Journal:  BMJ Case Rep       Date:  2020-09-28

Review 6.  Clinical Features of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus and Other Connective Tissue Diseases.

Authors:  Tsuyoshi Kasama; Airi Maeoka; Nao Oguro
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2016-01-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.